The global assisted reproductive technology market size was valued at USD 31.63 billion in 2025 and is projected to grow from USD 35.09 billion in 2026 to USD 80.58 billion by 2034, registering a CAGR of 10.95% during the forecast period from 2026 to 2034. Europe dominated the assisted reproductive technology market with a market share of 38.6% in 2025.
Assisted reproductive technology (ART) refers to a group of medical procedures used to help individuals and couples achieve pregnancy by handling eggs, sperm, or embryos under controlled laboratory conditions. These procedures include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), embryo freezing, and embryo transfer. ART is widely used to address infertility, genetic conditions, and age-related reproductive challenges while improving the chances of successful conception.
Download a Free Sample To learn more about this report,
Increasing Integration of Artificial Intelligence in Fertility Treatment
Artificial intelligence is becoming increasingly integrated into assisted reproductive technology workflows, particularly in embryo assessment, sperm evaluation, treatment planning, and laboratory decision support. AI-based systems can process large volumes of imaging and clinical data to support more consistent assessments and help fertility specialists identify embryos with stronger developmental potential. This trend is encouraging fertility centers to adopt data-driven laboratory processes while improving the standardization and efficiency of reproductive treatment.
Growing Adoption of Fertility Preservation Procedures
Fertility preservation is expanding the role of assisted reproductive technology beyond immediate infertility treatment. Increasing awareness of planned egg freezing, medical fertility preservation, and reproductive planning is encouraging individuals to preserve reproductive potential for future use. This is creating additional demand for oocyte retrieval, cryopreservation, storage, and subsequent thawing services while broadening the patient base served by fertility clinics.
Rising Infertility Prevalence and Delayed Parenthood
The assisted reproductive technology market is expanding due to the increasing prevalence of infertility and the growing trend of delayed parenthood worldwide. According to the World Health Organization, approximately 1 in 6 adults globally experience infertility during their lifetime, significantly increasing the need for fertility care. Lifestyle changes, obesity, stress, reproductive disorders, and increasing maternal age are further contributing to infertility-related healthcare needs. Growing awareness of fertility treatment options and greater willingness to seek professional reproductive care are also supporting demand for assisted reproductive technology services.
High Treatment Costs Restrict Access to Assisted Reproductive Technology
The financial burden associated with assisted reproductive technology remains a major limitation to broader adoption. IVF and related treatments can require repeated clinical procedures, medications, laboratory services, embryo storage, and additional testing, resulting in substantial out-of-pocket expenses where insurance or public financing is limited. High treatment costs can therefore delay treatment, reduce the number of cycles patients can pursue, and restrict access among lower-income populations.
Expansion of Fertility Care in Underserved Regions Creates Growth Opportunities
Expanding fertility services beyond established metropolitan centers creates opportunities for assisted reproductive technology providers to reach previously underserved patient populations. Investment in fertility clinics, laboratory infrastructure, trained specialists, diagnostic capabilities, and standardized treatment pathways can increase access in emerging markets and secondary cities. Greater geographic availability can also support earlier diagnosis and reduce the need for patients to travel long distances for specialized reproductive care.
Differences in Regulatory and Ethical Requirements Complicate ART Service Expansion
Assisted reproductive technology operates within complex regulatory and ethical frameworks covering embryo handling, genetic testing, donor materials, cryopreservation, consent, and third-party reproduction. Requirements differ substantially between jurisdictions, creating operational complexity for clinics, laboratories, technology providers, and patients seeking treatment across borders. Maintaining compliance while preserving consistent clinical standards can increase administrative requirements and complicate the expansion of standardized ART services internationally.
In Vitro Fertilization (IVF) Dominated the Market with 83.2% Share in 2025
In Vitro Fertilization (IVF) accounted for the largest share of the global assisted reproductive technology market at 83.2% in 2025, driven by its higher success rates, increasing infertility cases, continuous technological advancements, and growing preference for advanced fertility treatments.
Request Customizationto receive a tailored report.
Frozen Non-Donor is Projected to Register the Fastest Growth at a CAGR of 9.42%
The Frozen Non-Donor segment is expected to expand at the highest CAGR of 9.42% during 2026–2034, supported by improved embryo cryopreservation techniques, higher implantation success rates, and increasing adoption of frozen embryo transfer procedures.
Intrauterine (IUI) Emerged as the Leading AI Segment with 61.5% Market Share in 2025
The Intrauterine (IUI) segment held the largest market share of 61.5% in 2025, owing to its high clinical success rate, affordability, minimally invasive procedure, and widespread use as a first-line fertility treatment.
Software and AI Solutions are Projected to Register the Fastest Growth at a CAGR of 11.42%
The Software and AI Solutions segment is anticipated to witness the fastest growth, registering a CAGR of 11.42% during 2026–2034, driven by the increasing adoption of artificial intelligence for embryo selection, treatment planning, laboratory automation, and workflow optimization.
Fertility Clinics and Specialized Facilities Dominated the Market with 78.4% Share in 2025
Fertility clinics and specialized facilities accounted for the largest share of the global assisted reproductive technology market at 78.4% in 2025, supported by the availability of specialized reproductive care, experienced fertility professionals, advanced treatment technologies, and higher patient preference for dedicated fertility centers.
Speak to an Analystto discuss market opportunities.
Europe dominated the global Assisted Reproductive Technology market with a 38.6% market share, valued at USD 12.21 billion in 2025. The region benefits from advanced healthcare infrastructure, increasing infertility treatment adoption, favorable reimbursement policies in several countries, and continuous technological advancements in fertility clinics. Rising maternal age, growing awareness of fertility preservation, and expanding access to assisted reproductive procedures continue to drive market growth across Europe.
Germany accounted for an estimated USD 3.42 billion of the market in 2025, making it the largest contributor in Europe. Growth is supported by the country's advanced fertility treatment infrastructure, increasing infertility prevalence, expanding adoption of IVF procedures, and the presence of specialized fertility clinics offering advanced reproductive technologies.
The United Kingdom represented an estimated USD 2.44 billion in 2025. Increasing NHS and private fertility treatment services, rising awareness of assisted conception, growing demand for egg freezing, and expanding access to advanced reproductive technologies are driving steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
North America accounted for 29.4% of the global assisted reproductive technology market, reaching USD 9.30 billion in 2025. The region benefits from advanced fertility care infrastructure, high healthcare expenditure, widespread adoption of IVF and related procedures, and strong technological innovation in reproductive medicine. Increasing infertility rates, delayed parenthood, and growing acceptance of fertility preservation continue to support regional market expansion.
The United States accounted for an estimated USD 7.91 billion of the market in 2025, making it the largest contributor in North America. Growth is driven by increasing utilization of IVF procedures, rising investments in fertility clinics, expanding insurance coverage for reproductive treatments in selected states, and continuous technological advancements in assisted reproductive medicine.
Canada generated an estimated USD 1.39 billion in 2025. Rising government support for fertility care, increasing awareness of infertility treatments, expanding access to IVF services, and growing investments in reproductive healthcare are contributing to sustained market growth across the country.
Asia Pacific accounted for 22.7% of the global assisted reproductive technology market, valued at USD 7.18 billion in 2025, and is projected to register the fastest CAGR of 10.46% during the forecast period. Rapid improvements in healthcare infrastructure, increasing infertility prevalence, rising disposable incomes, growing medical tourism, and expanding availability of advanced fertility treatments are accelerating market growth across the region.
Japan generated an estimated USD 1.29 billion in 2025. The country's aging population, declining birth rate, expanding government support for fertility treatments, and widespread adoption of advanced assisted reproductive technologies continue to support market expansion.
China accounted for an estimated USD 3.02 billion in 2025, making it the largest market in the Asia Pacific. Government initiatives to address declining birth rates, increasing fertility clinic investments, expanding reproductive healthcare services, and rising awareness of infertility treatment options continue to drive strong market growth.
The Middle East & Africa represented 4.0% of the global assisted reproductive technology market, totaling USD 1.27 billion in 2025. Increasing investments in healthcare infrastructure, growing infertility awareness, expanding fertility treatment centers, and rising adoption of advanced reproductive technologies are supporting market growth across the region.
The United Arab Emirates (UAE) accounted for an estimated USD 0.30 billion in 2025. The country's market is driven by expanding fertility clinics, increasing medical tourism, supportive healthcare investments, and rising demand for advanced assisted reproductive procedures among local and international patients.
Africa is witnessing steady growth in the assisted reproductive technology market, supported by improving access to fertility care, increasing investments in reproductive healthcare infrastructure, growing awareness of infertility treatment, and expanding private fertility clinics. Countries such as South Africa, Egypt, Kenya, and Nigeria are strengthening reproductive healthcare services, creating long-term growth opportunities for assisted reproductive technology providers.
The global assisted reproductive technology market includes major fertility treatment providers, reproductive health companies, laboratory technology specialists, sperm and egg banking organizations, and fertility clinic networks competing through treatment outcomes, advanced reproductive technologies, laboratory capabilities, geographic reach, and patient-centric care. CooperSurgical, Ferring Pharmaceuticals, Hamilton Thorne, Vitrolife, Genea, California Cryobank, European Sperm Bank, INVO Bioscience, Monash IVF Group, and Progyny compete across in vitro fertilization, embryo culture, fertility preservation, reproductive laboratory equipment, genetic testing, and fertility care services. Competition is shifting toward advanced embryo selection, time-lapse imaging, cryopreservation, minimally invasive fertility technologies, genetic screening, and personalized reproductive care to improve treatment success rates. Companies are also investing in laboratory automation, artificial intelligence, digital fertility platforms, expanded clinic networks, and innovative reproductive technologies while strengthening partnerships with fertility specialists, healthcare providers, and research institutions to improve accessibility, treatment outcomes, and patient experience.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Europe Tangential Flow Filtration Market Size, Share & Trends | Industry Report, 2034
Asia Pacific Genetic Testing Market Size, 2034
North America TB Diagnostics Market Size & Trends Analysis, 2034
U.S Direct to Consumer Laboratory Testing Market Size, Share and Forecast to 2034
Non-invasive Prenatal Testing Market Size, Share, Growth, 2034
Vaccines Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com